Gastrinoma: New medical and surgical approaches

Thomas Howard, E. Passaro

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The clinical presentation of gastrinoma has changed since the original description by Zollinger and Ellison in 1955. Tumors currently found are smaller, extrapancreatic or extraintestinal in location, and frequently occult within lymph nodes. The incidence of hepatic metastases on initial presentation has decreased. In addition, the clinical course of patients with tumor in lymph nodes is benign, suggesting that more patients than were previously thought are now candidates for cure. Improved knowledge of the anatomic location of gastrinomas has enhanced our ability to find and remove them at laparotomy. As a result of these factors, more patients are being cured than ever before, and in the future, cure rate may be even higher. On the basis of these advances, the optimal treatment of gastrinoma is surgical excision for cure.

Original languageEnglish (US)
Pages (from-to)667-681
Number of pages15
JournalSurgical Clinics of North America
Volume69
Issue number3
StatePublished - 1989
Externally publishedYes

Fingerprint

Gastrinoma
Lymph Nodes
Laparotomy
Neoplasms
Neoplasm Metastasis
Liver
Incidence
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Gastrinoma : New medical and surgical approaches. / Howard, Thomas; Passaro, E.

In: Surgical Clinics of North America, Vol. 69, No. 3, 1989, p. 667-681.

Research output: Contribution to journalArticle

@article{42c9d2556840409482f44ed01d751b6d,
title = "Gastrinoma: New medical and surgical approaches",
abstract = "The clinical presentation of gastrinoma has changed since the original description by Zollinger and Ellison in 1955. Tumors currently found are smaller, extrapancreatic or extraintestinal in location, and frequently occult within lymph nodes. The incidence of hepatic metastases on initial presentation has decreased. In addition, the clinical course of patients with tumor in lymph nodes is benign, suggesting that more patients than were previously thought are now candidates for cure. Improved knowledge of the anatomic location of gastrinomas has enhanced our ability to find and remove them at laparotomy. As a result of these factors, more patients are being cured than ever before, and in the future, cure rate may be even higher. On the basis of these advances, the optimal treatment of gastrinoma is surgical excision for cure.",
author = "Thomas Howard and E. Passaro",
year = "1989",
language = "English (US)",
volume = "69",
pages = "667--681",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Gastrinoma

T2 - New medical and surgical approaches

AU - Howard, Thomas

AU - Passaro, E.

PY - 1989

Y1 - 1989

N2 - The clinical presentation of gastrinoma has changed since the original description by Zollinger and Ellison in 1955. Tumors currently found are smaller, extrapancreatic or extraintestinal in location, and frequently occult within lymph nodes. The incidence of hepatic metastases on initial presentation has decreased. In addition, the clinical course of patients with tumor in lymph nodes is benign, suggesting that more patients than were previously thought are now candidates for cure. Improved knowledge of the anatomic location of gastrinomas has enhanced our ability to find and remove them at laparotomy. As a result of these factors, more patients are being cured than ever before, and in the future, cure rate may be even higher. On the basis of these advances, the optimal treatment of gastrinoma is surgical excision for cure.

AB - The clinical presentation of gastrinoma has changed since the original description by Zollinger and Ellison in 1955. Tumors currently found are smaller, extrapancreatic or extraintestinal in location, and frequently occult within lymph nodes. The incidence of hepatic metastases on initial presentation has decreased. In addition, the clinical course of patients with tumor in lymph nodes is benign, suggesting that more patients than were previously thought are now candidates for cure. Improved knowledge of the anatomic location of gastrinomas has enhanced our ability to find and remove them at laparotomy. As a result of these factors, more patients are being cured than ever before, and in the future, cure rate may be even higher. On the basis of these advances, the optimal treatment of gastrinoma is surgical excision for cure.

UR - http://www.scopus.com/inward/record.url?scp=0024308275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024308275&partnerID=8YFLogxK

M3 - Article

C2 - 2567061

AN - SCOPUS:0024308275

VL - 69

SP - 667

EP - 681

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 3

ER -